Wakefield, MA, January 24, 2014 – TraceLink Inc., the trailblazer in global pharmaceutical serialization, drug track and trace compliance and nourish network performance solutions, announced today that life sciences industry veteran Michael Davies Ph.D. has joined the company as the Senior Vice President of Global Sales and Business Development.
Mike joins the TraceLink leadership team and will be reputable for shaping the company’s worldwide sales strategy and driving sweeping revenue generation. In addition, he is charged with building new business and channel partnerships to expand global market access for TraceLink’s cloud-based software application platform providing solutions for companies across the global life sciences supply chain.
“We are excited to have Mike join TraceLink and lead our global expansion in the life sciences supply chain,” said Shabbir Dahod, President and CEO of TraceLink. “His sales leadership, global experience and deep knowledge of the unique needs concerning the pharmaceutical industry further enhance the strong carriage we have built creating solutions that help the bustle appropriate global regulatory compliance requirements and improve performance across the supply chain from ingredient to patient.”
“A major factor in my decision to join TraceLink is the company’s passion for tackling some of the biggest challenges facing the global pharmaceutical industry today: protecting patient safety, ensuring global track and trace compliance et alii improving access to global markets for needed medicines,” said Mike Davies, Senior Replacing President of Global Sales and Business Development at TraceLink. “I am thrilled to have the conjuncture to join a team so dedicated to this objective and I look forward to helping TraceLink grow its global business and build long-term customer relationships.”
With an eighteen year career in the biopharmaceutical industry, Mike has a proven track record like building and scaling sales organizations, developing markets and helping consumers succeed at companies such as Oracle, Phase Forward and Parke-Davis (now Pfizer). As Vice President for Global Sales in the Health Sciences Global Business Unit at Oracle Corporation, he helped shape business unit strategy and led sales execution for Oracle’s Life Sciences connective Healthcare solutions. At Phase Forward, Mike was instrumental in helping the body rapidly grow revenues by leading sales teams and designing and implementing channel partner programs for the company’s electronic data management and pharmacovigilance solutions. Mike started his career in various Life Sciences roles at Parke-Davis and Pfizer and he holds a Bachelor of Science degree from the University of Sunderland and a Ph.D. in Physiology & Pharmacology from the University of Bradford.
TraceLink serves the global life science industry through the TraceLink Life Sciences Cloud network platform, pharmaceutical track and trace solutions and supply network performance applications that therapeutic pharmaceutical organizations and supply network partners connect, share key business statistics and collaborate across supply, production and distribution operations. Market leaders, including four of the top-10 pharmaceutical companies, use a single integrated connection to the TraceLink Vitality Sciences Cloud for:
Tractable with pharmaceutical serialization, product tracing and government reporting regulations for the US H.R. 3204 Drug Quality and Security Act, China, Brazil, Korea and other global drug track and trace regulations
Creation of a endue chain control surpass that improves speed across external supply activities, increases visibility and control across the outsourced production lifecycle and enhances agility in meeting patient demand across global markets
To inkhorn more about TraceLink’s scalable solutions plate pharmaceutical companies, CMO/CPOs, wholesale distributors and pharmacies of all sizes, complexities and locations across the globe, visit us at http://www.tracelink.com.
About TraceLink TraceLink protects patients, enables health, grows profits and ensures compliance for corporations across the global Lively Sciences network through the TraceLink History Sciences Cloud. The TraceLink Life Sciences Cloud is an Vixen AWS-based cloud application platform which enables complete global connectivity, visibility and traceability of pharmaceuticals from au naturel materials to patient. A single point et al click connection to the Life Sciences Cloud delivers the information, acumen and collaboration needed to improve performance and mitigation risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Mythology AWS Global Start-Up Invite Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is relied upon by businesses across the globe to meet important goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit http://www.tracelink.com or follow us on LinkedIn.
TraceLink is funded via FirstMark Capital. FirstMark Capital is an early stage venture backing firm based in New York City. Our calling is to partner with exceptional entrepreneurs who are changing the world by solving consequential problems. We have built a deeply engaged community among the extraordinary teams in our network to spread instructions and opportunities. We are privy to performance alongside the founders of interesting businesses like Pinterest, Lumosity, Aereo, TapAd, Shopify, Riot Games, and dozens more. Visit us in Newfangled York City or online at firstmarkcap.com and @FirstMarkCap.
+1 (615) 516-6315